ATC
GCVRZ

Adirondack Trust Company’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Adirondack Trust Company’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-35
Closed – – 366
2015
Q2 		$0 Hold
35
– – ﹤0.01% 367
2015
Q1 		$0 Hold
35
– – ﹤0.01% 374
2014
Q4 		$0 Hold
35
– – ﹤0.01% 355
2014
Q3 		$0 Hold
35
– – ﹤0.01% 358
2014
Q2 		$0 Hold
35
– – ﹤0.01% 343
2014
Q1 		$0 Hold
35
– – ﹤0.01% 318
2013
Q4 		$0 Hold
35
– – ﹤0.01% 313
2013
Q3 		$0 Hold
35
– – ﹤0.01% 316
2013
Q2 		$0 Buy
+35
New +$61 ﹤0.01% 310

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Adirondack Trust Company's GCVRZ Position: Q3 2015 in Review

Adirondack Trust Company sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2015, closing a stake of 35 shares.

Adirondack Trust Company first reported a position in GCVRZ in Q2 2013 and held it in 9 quarters. The position peaked at $0 in Q2 2015. 117 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2015.

  • Adirondack Trust Company reported no remaining Sanofi Contingent Value Rights position as of Q3 2015 after selling out during the quarter.
  • Adirondack Trust Company sold 35 Sanofi Contingent Value Rights shares in Q3 2015.
  • Adirondack Trust Company first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 9 quarters.
  • Adirondack Trust Company's Sanofi Contingent Value Rights position peaked at $0 in Q2 2015.
  • 117 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2015.

Based on Adirondack Trust Company's 13F filing for Q3 2015, filed 19 Oct 2015.